Endothelial Rictor is crucial for midgestational development and sustained and extensive FGF2-induced neovascularization in the adult

[1]  S. Khaliq,et al.  Involvement of vascular endothelial growth factor (VEGF) gene polymorphism in hepatocellular carcinoma of HCV patients from local population , 2017 .

[2]  A. Józkowicz,et al.  Cellular and molecular mechanisms of inflammation‐induced angiogenesis , 2015, IUBMB life.

[3]  Christopher C W Hughes,et al.  A role for partial endothelial-mesenchymal transitions in angiogenesis? , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Dana M. Brantley-Sieders,et al.  Regulation of Endothelial Cell Proliferation and Vascular Assembly through Distinct mTORC2 Signaling Pathways , 2015, Molecular and Cellular Biology.

[5]  J. Pratap,et al.  Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells , 2014, Breast Cancer Research.

[6]  L. Zimmerli,et al.  Rictor in Perivascular Adipose Tissue Controls Vascular Function by Regulating Inflammatory Molecule Expression , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Leung,et al.  Fibroblast Growth Factor 2 Induces E-Cadherin Down-Regulation via PI3K/Akt/mTOR and MAPK/ERK Signaling in Ovarian Cancer Cells , 2013, PloS one.

[8]  S. Dedhar,et al.  Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial–mesenchymal transition (EMT) , 2013, Oncogene.

[9]  G. Christofori,et al.  Sprouty2 expression controls endothelial monolayer integrity and quiescence , 2013, Angiogenesis.

[10]  R. Kalluri,et al.  Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. , 2012, Seminars in cancer biology.

[11]  E. Battegay,et al.  Loss of Pim1 Imposes a Hyperadhesive Phenotype on Endothelial Cells , 2012, Cellular Physiology and Biochemistry.

[12]  D. Medici,et al.  The role of endothelial‐mesenchymal transition in heterotopic ossification , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  H. Moch,et al.  Tumor Cell Plasticity and Angiogenesis in Human Melanomas , 2012, PloS one.

[14]  James W. Smyth,et al.  TGF-β-induced activation of mTOR complex 2 drives epithelial–mesenchymal transition and cell invasion , 2012, Journal of Cell Science.

[15]  J. Ward,et al.  The Utility of Immunohistochemistry for the Identification of Hematopoietic and Lymphoid Cells in Normal Tissues and Interpretation of Proliferative and Inflammatory Lesions of Mice and Rats , 2012, Toxicologic pathology.

[16]  R. Muschel,et al.  Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature. , 2012, Cancer research.

[17]  T. Kishimoto,et al.  Turn motif phosphorylation negatively regulates activation loop phosphorylation in Akt , 2011, Oncogene.

[18]  P. Giovanoli,et al.  In vivo visualization of the origination of skin graft vasculature in a wild-type/GFP crossover model. , 2011, Microvascular research.

[19]  Lei Xu,et al.  Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.

[20]  D. McDonald,et al.  Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors. , 2011, Cancer research.

[21]  Jennifer L. Doyle,et al.  Identification of a mechanism underlying regulation of the anti-angiogenic forkhead transcription factor FoxO1 in cultured endothelial cells and ischemic muscle. , 2011, The American journal of pathology.

[22]  Yanlei Ma,et al.  The relationship between early embryo development and tumourigenesis , 2010, Journal of cellular and molecular medicine.

[23]  M. Iruela-Arispe,et al.  Vascular remodeling of the vitelline artery initiates extravascular emergence of hematopoietic clusters. , 2010, Blood.

[24]  S. Krane,et al.  Stromal regulation of vessel stability by MMP14 and TGFβ , 2010, Disease Models & Mechanisms.

[25]  H. Kleinman,et al.  In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract , 2010, Nature Protocols.

[26]  R. Kalluri,et al.  Conversion of vascular endothelial cells into multipotent stem-like cells , 2010, Nature Medicine.

[27]  V. Arruda,et al.  Dual gene transfer of fibroblast growth factor-2 and platelet derived growth factor-BB using plasmid deoxyribonucleic acid promotes effective angiogenesis and arteriogenesis in a rodent model of hindlimb ischemia. , 2009, Translational research : the journal of laboratory and clinical medicine.

[28]  Peter Carmeliet,et al.  Mechanisms of Vessel Branching: Filopodia on Endothelial Tip Cells Lead the Way , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[29]  D. Guertin,et al.  mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. , 2009, Cancer cell.

[30]  M. Menger,et al.  A New Model for Studying the Revascularization of Skin Grafts In Vivo: The Role of Angiogenesis , 2008, Plastic and reconstructive surgery.

[31]  E. Casanova,et al.  Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. , 2008, Cell metabolism.

[32]  J. Auwerx,et al.  Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. , 2008, Cell metabolism.

[33]  C. Schnell,et al.  Effects of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 on the tumor vasculature: implications for clinical imaging. , 2008, Cancer research.

[34]  K. Inoki,et al.  Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling , 2008, The EMBO journal.

[35]  Daniela Gabriel,et al.  Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity , 2008, Molecular Cancer Therapeutics.

[36]  Elizabeth D. Wederell,et al.  Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. , 2008, Cancer research.

[37]  Thomas D. Schmittgen,et al.  Real-time PCR quantification of precursor and mature microRNA. , 2008, Methods.

[38]  M. Guba,et al.  Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis , 2007, Cancer and Metastasis Reviews.

[39]  C. Ruhrberg,et al.  Selective requirements for NRP1 ligands during neurovascular patterning , 2007, Development.

[40]  R. Behringer,et al.  Staining Whole Mouse Embryos for {beta}-Galactosidase (lacZ) Activity. , 2007, CSH protocols.

[41]  S. Cohen,et al.  Re-evaluating AKT regulation: role of TOR complex 2 in tissue growth. , 2007, Genes & development.

[42]  E. Hofer,et al.  Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis , 2007, Thrombosis and Haemostasis.

[43]  M. Hall,et al.  Hypoxia-Induced Endothelial Proliferation Requires Both mTORC1 and mTORC2 , 2007, Circulation research.

[44]  D. Guertin,et al.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.

[45]  Jackelyn A. Alva,et al.  VE‐cadherin‐CreERT2 transgenic mouse: A model for inducible recombination in the endothelium , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[46]  J. Qin,et al.  SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.

[47]  J. Woo,et al.  Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. , 2006, Developmental cell.

[48]  H. Kawamura,et al.  Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions. , 2006, Experimental cell research.

[49]  D. Sabatini,et al.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.

[50]  P. Carmeliet,et al.  VE‐Cadherin‐Cre‐recombinase transgenic mouse: A tool for lineage analysis and gene deletion in endothelial cells , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[51]  D. Sabatini,et al.  Growing roles for the mTOR pathway. , 2005, Current opinion in cell biology.

[52]  P. Dell’Era,et al.  Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. , 2005, Cytokine & growth factor reviews.

[53]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[54]  M. Medina,et al.  Angiogenesis and signal transduction in endothelial cells , 2004, Cellular and Molecular Life Sciences CMLS.

[55]  S. Kiselev,et al.  Molecular Mechanisms of Tumor Angiogenesis , 2003, Biochemistry (Moscow).

[56]  R. Auerbach,et al.  The sponge/Matrigel angiogenesis assay , 2004, Angiogenesis.

[57]  W. Gerald,et al.  Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. , 2003, Cancer cell.

[58]  Jeffrey Malik,et al.  Circulation is established in a stepwise pattern in the mammalian embryo. , 2003, Blood.

[59]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[60]  P. Marie,et al.  FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. , 2002, Genes & development.

[61]  T. Resink,et al.  Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR) ‐dependent signaling , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  A. Copp,et al.  Blocking endogenous FGF-2 activity prevents cranial osteogenesis. , 2002, Developmental biology.

[63]  G. Koehl,et al.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor , 2002, Nature Medicine.

[64]  C. Dani,et al.  Impaired ossification in mice lacking the transcription factor Sp3 , 2001, Mechanisms of Development.

[65]  L. Claesson‐Welsh,et al.  FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. , 2001, Trends in pharmacological sciences.

[66]  Nobuyuki Itoh,et al.  Fibroblast growth factors , 2001, Genome Biology.

[67]  K. Claffey,et al.  Fibroblast Growth Factor 2 Activation of Stromal Cell Vascular Endothelial Growth Factor Expression and Angiogenesis , 2001, Laboratory Investigation.

[68]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[69]  T. Mohr,et al.  Evidence for a role of FGF‐2 and FGF receptors in the proliferation of non‐small cell lung cancer cells , 1999, International journal of cancer.

[70]  P. Davol,et al.  Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: Characterizing and circumventing mechanisms of tumor resistance , 1999, The Prostate.

[71]  M. Sabbieti,et al.  Parathyroid Hormone Regulates the Expression of Fibroblast Growth Factor‐2 mRNA and Fibroblast Growth Factor Receptor mRNA in Osteoblastic Cells , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[72]  Y. Takai,et al.  Immunohistochemical study of fibroblast growth factor-2 (FGF-2) and fibroblast growth factor receptor (FGF-R) in experimental squamous cell carcinoma of rat submandibular gland. , 1999, Oral oncology.

[73]  Daniel B. Rifkin,et al.  Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis , 1998, The Journal of cell biology.

[74]  M. Tsuneyoshi,et al.  Expressions of basic fibroblast growth factor and fibroblast growth factor receptor mRNA in soft tissue tumors by in situ hybridization. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[75]  M. Ittman,et al.  Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. , 1997, The Journal of urology.

[76]  D. Birnbaum,et al.  Expression of FGF1 and FGFR1 in human melanoma tissues , 1996, Melanoma research.

[77]  M. Tsuneyoshi,et al.  Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma , 1995, The Journal of pathology.

[78]  R. Florkiewicz,et al.  Quantitative export of FGF‐2 occurs through an alternative, energy‐dependent, non‐ER/Golgi pathway , 1995, Journal of cellular physiology.

[79]  Cord Sunderkötter,et al.  Macrophages and angiogenesis , 1994, Journal of leukocyte biology.

[80]  M. Klagsbrun,et al.  Purification of cartilage-derived growth factor by heparin affinity chromatography. , 1985, The Journal of biological chemistry.